eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. eLetters are not edited, proofread, or indexed. Please read our Terms of Service before submitting your own eLetter.
Research ArticleB CELLS
Inhibition of IL-2 responsiveness by IL-6 is required for the generation of GC-TFH cells
- Amber Papillion1,
- Michael D. Powell2,3,
- Danielle A. Chisolm4,
- Holly Bachus1,
- Michael J. Fuller1,
- Amy S. Weinmann4,
- Alejandro Villarino5,
- John J. O’Shea5,
- Beatriz León4,
- Kenneth J. Oestreich2,6,7 and
- André Ballesteros-Tato1,*
- 1Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
- 2Virginia Tech Carilion Research Institute, Roanoke, VA, USA.
- 3Translational Biology, Medicine, and Health Graduate Program, Virginia Tech Carilion Research Institute, Roanoke, VA, USA.
- 4Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.
- 5Molecular Immunology and Inflammation Branch, NIAMS, NIH, Bethesda, MD, USA.
- 6Virginia Tech Carilion School of Medicine, Roanoke, VA, USA.
- 7Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA, USA.
- ↵*Corresponding author. Email: andreballesterostato{at}uabmc.edu
See allHide authors and affiliations
Science Immunology 13 Sep 2019:
Vol. 4, Issue 39, eaaw7636
DOI: 10.1126/sciimmunol.aaw7636
Vol. 4, Issue 39, eaaw7636
DOI: 10.1126/sciimmunol.aaw7636
Amber Papillion
Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Michael D. Powell
Virginia Tech Carilion Research Institute, Roanoke, VA, USA.Translational Biology, Medicine, and Health Graduate Program, Virginia Tech Carilion Research Institute, Roanoke, VA, USA.
Danielle A. Chisolm
Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.
Holly Bachus
Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Michael J. Fuller
Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Amy S. Weinmann
Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.
Alejandro Villarino
Molecular Immunology and Inflammation Branch, NIAMS, NIH, Bethesda, MD, USA.
John J. O’Shea
Molecular Immunology and Inflammation Branch, NIAMS, NIH, Bethesda, MD, USA.
Beatriz León
Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.
Kenneth J. Oestreich
Virginia Tech Carilion Research Institute, Roanoke, VA, USA.Virginia Tech Carilion School of Medicine, Roanoke, VA, USA.Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA, USA.
André Ballesteros-Tato
Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Submit a Response to This Article
No eLetters have been published for this article.